CIT’s healthcare finance served as lead arranger of $135.6 million in financing for Superior Biologics. The financing of a term loan and a revolving line of credit, will be used to refinance existing debt, fund a shareholder dividend, provide working capital and support growth initiatives.
Superior Biologics is a provider of specialty pharmacy and home infusion therapy services to patients contending with a wide variety of chronic illnesses located in Sharon Hill, PA. It operates seven accredited pharmacies across the U.S., serving patients in 43 states and having the capability to dispense medications in all 50 states.
“Our innovative and cost-effective pharmacy and in-home nursing infusion services help lead to optimal therapeutic outcomes and best-in-class patient results,” Ray Mirra, founder and CEO of Superior Biologics, said. “We appreciated CIT’s agility and expertise in arranging financing that supports our business objectives.”
“We were pleased to again support Superior Biologics with another financing package tailored to advance their business goals,” William Douglass, managing director and group head – healthcare finance at CIT, said.
“We always work closely with Superior Biologics to understand their needs,” David Gibbs, managing director in healthcare finance at CIT, said. “It is a pleasure to work with smart and successful companies and we look forward to continuing our association in the future.”
